Loracarbef Interactions
There are 46 drugs known to interact with loracarbef, along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 6 are major, and 40 are moderate.
- View all 46 medications that may interact with loracarbef
- View loracarbef alcohol/food interactions (1)
- View loracarbef disease interactions (4)
Most frequently checked interactions
View interaction reports for loracarbef and the medicines listed below.
- Adcetris (brentuximab)
- Adriamycin (doxorubicin)
- Advate (antihemophilic factor)
- Bivigam (immune globulin intravenous)
- Braftovi (encorafenib)
- Brethine (terbutaline)
- Brevibloc (esmolol)
- Centrum (multivitamin with minerals)
- Coreg (carvedilol)
- Cytoxan (cyclophosphamide)
- D3 (cholecalciferol)
- Diacomit (stiripentol)
- Emgality (galcanezumab)
- Esidrix (hydrochlorothiazide)
- Etopophos (etoposide)
- Givlaari (givosiran)
- Infuvite Pediatric (multivitamin)
- Ingrezza (valbenazine)
- Janumet (metformin / sitagliptin)
- Juluca (dolutegravir / rilpivirine)
- L Thyroxine Roche (levothyroxine)
- Lanoxin (digoxin)
- Lortab (acetaminophen / hydrocodone)
- Mavik (trandolapril)
- Mektovi (binimetinib)
- Mepron (atovaquone)
- Meticorten (prednisone)
- Multitrace-4 Pediatric (trace elements)
- Oncovin (vincristine)
- Perikabiven (parenteral nutrition solution w/electrolytes)
Loracarbef alcohol/food interactions
There is 1 alcohol/food interaction with loracarbef.
Loracarbef disease interactions
There are 4 disease interactions with loracarbef which include:
Report options
QR code containing a link to this page
More about loracarbef
- loracarbef consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: second generation cephalosporins
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
